Cancer is one of the most frequently diagnosed malignant diseases worldwide, posing a
serious, long-term threat to patients' health and life. Systemic chemotherapy remains the first …

Craniopharyngioma (CP) is a rare intracranial tumor arising from the epithelial remnants of
Rathke's pouch, most frequently originating in the sellar/parasellar region. Histologically, CP …

Objective Targeted therapy (TT) with BRAF/MEK inhibitors has emerged as a potential
treatment in papillary craniopharyngiomas (PCPs). However, standardized data on large …

Abstract In 2021, the World Health Organization released the fifth edition of the central
nervous system (CNS) tumor classification. This classification uses histopathology and …

Simple Summary Craniopharyngiomas are benign but complex WHO grade I extra-axial
epithelial neoplasms. Their infiltrative nature towards adjacent structures, such as the …

Opinion statement The integration of targeted therapy into the multimodal management of
craniopharyngiomas represents a significant advancement in the field of neuro-oncology …

Purpose: The goal of this study was to develop end-to-end convolutional neural network
(CNN) models that can noninvasively discriminate papillary craniopharyngioma (PCP) from …

Introduction Optimal planning and minimally invasive surgical approach are essential to
complete craniopharyngiomas (CP) resection with limited postoperative morbidity. Given the …

BACKGROUND AND PURPOSE: Contrast-enhanced MRI (CEMRI) is a commonly used
imaging technique for craniopharyngioma surveillance; however, it carries risks such as …

Los tumores hipofisarios (TH) suponen el 15% de los tumores intracraneales, y afectan del
10, 7 al 14, 4% de la población, si bien la incidencia de los TH clínicamente relevantes es …